CE / CME
Xiomara Vega is a 39-year-old female presenting to her rheumatologist with persistent joint pain and stiffness despite ongoing treatment with a biologic medication.
Obesity is a clinically significant comorbidity in psoriatic arthritis, contributing to persistent inflammation, reduced biologic response, and increased cardiometabolic risk. Learners will explore how the bidirectional relationship between PsA and obesity shapes disease activity and practice integrating respectful, patient‑centered conversations and evidence‑based metabolic management into comprehensive PsA care.
Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit
Physicians: maximum of 0.50 AMA PRA Category 1 Credit™
Nurse Practitioners/Nurses: 0.50 Nursing contact hour
Released: August 14, 2026
Expiration: August 13, 2027
Share
Provided by Clinical Care Options LLC dba Decera Clinical Education in partnership with the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and Obesity Medicine Association (OMA).
This activity is supported by an educational grant from Lilly.
Lilly
Group for Research And Assessment for Psoriasis and Psoriatic Arthritis (GRAPPA)
Obesity Medicine Association (OMA)
This educational activity is intended for a primary target audience of rheumatologists, nurse practitioners, physician associates, and other healthcare professionals, such as a secondary audience of primary care practitioners and obesity specialists, who are involved in the care of patients with psoriatic arthritis and obesity.
The goal of this activity is to improve learners’ competence and confidence integrating obesity management into comprehensive care plans for patients with psoriatic arthritis.
Upon completion of this activity, participants should be able to:
Apply patient-centered communication strategies to effectively engage patients in discussions about weight and metabolic health as part of comprehensive PsA management
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Primary AuthorPhilip Mease, MD, MACR: consultant: AbbVie, Amgen, Bristol Myers Squibb, Century, Cullinan, Inmagene, Johnson & Johnson, Lilly, Merck, Moonlake, Novartis, Pfizer, Spyre, Sun, Takeda, Tonix, UCB; researcher: AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Johnson & Johnson, Lilly, Moonlake, Novartis, Sana, Takeda, UCB; speaker: AbbVie, Amgen, Johnson & Johnson, Lilly, Novartis, UCB.
The planners and content peer reviewers from Decera Clinical Education, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), and Obesity Medicine Association (OMA), do not have any relevant financial relationships to disclose, except Cayla Alexander, DNP, ARNP, Nicholas Pennings, DO and Julia
Swafford, PA-C, DFAAPA as noted below:
Cayla Alexander, DNP, ARNP: consultant: Novartis.
Nicholas Pennings, DO: independent contractor: Medifast; consultant/advisor/speaker: Abbott, Novo Nordisk.
Julia Swafford, PA-C, DFAAPA: consultant/advisor/speaker: Lilly.
Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 14, 2026, through August 13, 2027:
You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.
This program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Generative artificial intelligence (AI) tools were used for drafting educational content, revising or refining educational content, and generating clinical case(s) or scenario(s). All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.
The ACTiconsult platform is a unique AI-driven, voice-enabled technology designed to facilitate patient conversation, along with follow-up questions to help guide patient management decisions. Personalized recommendations provided in the ACTiconsult platform reflect AI-based interpretation of expert-informed management guidelines and are intended for educational purposes only. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Please verify all information and data before treating patients or using any therapies described in these materials.
Decera Clinical Education follows the guidelines outlined in the Guidance on the Responsible Use of Artificial Intelligence (AI) in Accredited Continuing Education (CE) document released by Joint Accreditation for Interprofessional Continuing Education in November 2025.
Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC dba Decera Clinical Education and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Clinical Care Options, LLC dba Decera Clinical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.
Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until August 13, 2027. PAs should only claim credit commensurate with the extent of their participation.
IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.